Efficacy and Tissue Distribution of DHP107, an Oral Paclitaxel Formulation

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Anticancer Efficacy and Toxicokinetics of a Novel Paclitaxel-Clofazimine Nanoparticulate Co-Formulation

Drug Delivery and Translational Research
Pharmaceutical Science
2015English

Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2015English

Enhanced Absorption and Tissue Distribution of Paclitaxel Following Oral Administration of DHP 107, a Novel Mucoadhesive Lipid Dosage Form

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Paclitaxel-Loaded Niosomes for Intravenous Administration: Pharmacokineticsand Tissue Distribution in Rats

Turkish Journal of Medical Sciences
Medicine
2015English

Novel Oral Formulation of Paclitaxel Inhibits Neointimal Hyperplasia in a Rat Carotid Artery Injury Model

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

A Novel, Palatable Paediatric Oral Formulation of Midazolam: Pharmacokinetics, Tolerability, Efficacy and Safety

Anaesthesia
AnesthesiologyPain Medicine
2018English

Arterial Paclitaxel Distribution and Deposition

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2000English

Treatment of Oral Cancer Using Magnetized Paclitaxel

Oncotarget
Oncology
2018English

Localized Delivery of Paclitaxel Using Elastic Liposomes: Formulation Development and Evaluation

Drug Delivery
MedicinePharmaceutical Science
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy